Profile | GDS2987 / GI_33356147-S |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 5.6 | 21 |
GSM215244 | HMVEC_vehicle_rep2 | 40.2 | 65 |
GSM215253 | HMVEC_vehicle_rep3 | 19.3 | 52 |
GSM215254 | HMVEC_atorvastatin_rep1 | 37.8 | 64 |
GSM215282 | HMVEC_atorvastatin_rep3 | 8.7 | 20 |
GSM215344 | HMVEC_atorvastatin_rep2 | 29.6 | 57 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 7.4 | 15 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 6.8 | 14 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 34.2 | 49 |
GSM215294 | HMVEC_SLx2119_rep1 | 6.6 | 24 |
GSM215295 | HMVEC_SLx2119_rep2 | 26.7 | 47 |
GSM215296 | HMVEC_SLx2119_rep3 | 26.7 | 41 |
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | ||
GSM215310 | PASMC_vehicle_rep3 | 2 | 3 |
GSM215311 | PASMC_atorvastatin_rep1 | 44.3 | 59 |
GSM215312 | PASMC_atorvastatin_rep2 | 35.1 | 49 |
GSM215313 | PASMC_atorvastatin_rep3 | 94.8 | 73 |
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | 74.6 | 70 |
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | 39.5 | 58 |
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | 28 | 44 |
GSM215327 | PASMC_SLx2119_rep1 | 3.4 | 6 |
GSM215328 | PASMC_SLx2119_rep2 | 60.3 | 67 |
GSM215329 | PASMC_SLx2119_rep3 | 50.5 | 64 |
GSM215330 | Fibroblasts_vehicle_rep1 | ||
GSM215331 | Fibroblasts_vehicle_rep2 | 28.2 | 58 |
GSM215332 | Fibroblasts_vehicle_rep3 | 23.7 | 57 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 30.3 | 59 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 11.3 | 31 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 23.5 | 49 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 1.7 | 6 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | ||
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 22 | 51 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 7.6 | 23 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 23.8 | 54 |
GSM215341 | Fibroblasts_SLx2119_rep3 |